Загрузка...
A view on dendritic cell immunotherapy in ovarian cancer: how far have we come?
Ovarian cancer is the second most important pelvic gynaecologic malignancy and nowadays still kills 80% of patients. New treatment options are mandatory. Although it has been shown that ovarian cancer is an immunogenic tumor, the possibility of developing immunotherapy has been neglected for a long...
| Главные авторы: | , , |
|---|---|
| Формат: | Online Статья Текст |
| Язык: | English |
| Опубликовано: |
Universa Press
2015
|
| Предметы: | |
| Online-ссылка: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402447/ https://www.ncbi.nlm.nih.gov/pubmed/25897374 |